Minimally Invasive Surgical Unit, Division of Colorectal Surgery, Adelaide and Meath Incorporating the National Childrens Hospital, Tallaght, Dublin 24, Ireland.
Int J Colorectal Dis. 2011 Oct;26(10):1309-15. doi: 10.1007/s00384-011-1261-1. Epub 2011 Jun 24.
For colorectal surgeons, laparoscopic rectal cancer surgery poses a new challenge. The defence of the questionable oncological safety tempered by the impracticality of the long learning curve is rapidly fading. As a unit specialising in minimally invasive surgery, we have routinely undertaken rectal cancer surgery laparoscopically since 2005.
Patients undergoing surgery for rectal cancer between June 2005 and February 2010 were retrospectively reviewed from a prospectively maintained colorectal cancer database.
One hundred and thirty patients underwent surgery for rectal cancer during the study period. One hundred and twenty patients had a laparoscopic resection, six were converted to open (conversion rate 5%) and 10 had a planned primary open procedure. Fifty four were low rectal tumours and 76 were upper rectal tumours. One hundred and thirteen patients had an anterior resection (87%), 17 patients an abdomino-perineal resection (13%) and 62 of the 130 patients (47.6%) had neoadjuvant radiotherapy. The median lymph node retrieval rate was 12 (9-14), five patients (3.8%) had a positive circumferential margin and the clinical anastomotic leak rate was 3.8% (n = 5 patients). There was no significant difference in the stated parameters for neoadjuvant versus non-neoadjuvant patients and for upper versus lower rectal tumours. Ninety three percent of mesorectal excision specimens were complete on pathological assessment.
During the study period, 92% of rectal cancers underwent a laparoscopic resection with low rates of morbidity and acceptable short-term oncological outcomes. This data supports the view that laparoscopic surgery for rectal cancer can be safely delivered in mid-volume centres by surgeons who have completed the learning curve for laparoscopic colorectal surgery.
对于结直肠外科医生来说,腹腔镜直肠肿瘤手术带来了新的挑战。长期学习曲线带来的不切实际性使得对可疑肿瘤安全性的担忧迅速消失。作为一个专门从事微创外科手术的单位,我们自 2005 年以来已常规进行腹腔镜直肠肿瘤手术。
从一个前瞻性维护的结直肠癌数据库中回顾性地研究了 2005 年 6 月至 2010 年 2 月期间接受直肠肿瘤手术的患者。
在研究期间,有 130 例患者接受了直肠肿瘤手术。120 例患者接受了腹腔镜切除术,6 例患者转为开放性手术(转化率为 5%),10 例患者计划进行原发性开放性手术。54 例为低位直肠肿瘤,76 例为高位直肠肿瘤。113 例患者接受了前切除术(87%),17 例患者接受了腹会阴切除术(13%),62 例患者(130 例患者的 47.6%)接受了新辅助放疗。中位淋巴结检出率为 12(9-14),5 例患者(3.8%)存在环周切缘阳性,临床吻合口漏发生率为 3.8%(n = 5 例)。新辅助与非新辅助患者以及上、下直肠肿瘤患者的上述参数无显著差异。93%的中直肠切除标本在病理评估时是完整的。
在研究期间,92%的直肠肿瘤患者接受了腹腔镜切除术,其发病率低,短期肿瘤学结果可接受。这些数据支持这样一种观点,即腹腔镜直肠肿瘤手术可以由已经完成腹腔镜结直肠手术学习曲线的外科医生在中等容量的中心安全地进行。